Literature DB >> 27654336

Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory.

Peera Hemarajata1, Jonathan D Baghdadi2, Risa Hoffman2, Romney M Humphries3.   

Abstract

Melioidosis is a potentially fatal infection caused by the bacterium Burkholderia pseudomallei Clinical diagnosis of melioidosis can be challenging since there is no pathognomonic clinical syndrome, and the organism is often misidentified by methods used routinely in clinical laboratories. Although the disease is more prevalent in Thailand and northern Australia, sporadic cases may be encountered in areas where it is not endemic, including the United States. Since the organism is considered a tier 1 select agent according to the Centers for Disease Control and Prevention and the U.S. Department of Agriculture Animal and Plant Health Inspection Service, clinical laboratories must be proficient at rapidly recognizing isolates suspicious for B. pseudomallei, be able to safely perform necessary rule-out tests, and to refer suspect isolates to Laboratory Response Network reference laboratories. In this minireview, we report a case of melioidosis encountered at our institution and discuss the laboratory challenges encountered when dealing with clinical isolates suspicious for B. pseudomallei or clinical specimens from suspected melioidosis cases.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27654336      PMCID: PMC5121373          DOI: 10.1128/JCM.01636-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  49 in total

1.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for rapid identification of Burkholderia pseudomallei: importance of expanding databases with pathogens endemic to different localities.

Authors:  Susanna K P Lau; Bone S F Tang; Shirly O T Curreem; Tsz-Ming Chan; Paolo Martelli; Cindy W S Tse; Alan K L Wu; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

2.  Misidentification of Burkholderia pseudomallei as Burkholderia cepacia by the VITEK 2 system.

Authors:  Zhiyong Zong; Xiaohui Wang; Yiyun Deng; Taoyou Zhou
Journal:  J Med Microbiol       Date:  2012-07-19       Impact factor: 2.472

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  The epidemiology of melioidosis in Australia and Papua New Guinea.

Authors:  B J Currie; D A Fisher; D M Howard; J N Burrow; S Selvanayagam; P L Snelling; N M Anstey; M J Mayo
Journal:  Acta Trop       Date:  2000-02-05       Impact factor: 3.112

5.  Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Adam Merritt; Glenys Chidlow; Max Aravena-Roman; Gerry Harnett
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

6.  Phylogenetic analysis of burkholderia species by multilocus sequence analysis.

Authors:  Paulina Estrada-de los Santos; Pablo Vinuesa; Lourdes Martínez-Aguilar; Ann M Hirsch; Jesús Caballero-Mellado
Journal:  Curr Microbiol       Date:  2013-02-13       Impact factor: 2.188

Review 7.  A Review of Melioidosis Cases in the Americas.

Authors:  Tina J Benoit; David D Blaney; Thomas J Doker; Jay E Gee; Mindy G Elrod; Dionne B Rolim; Timothy J J Inglis; Alex R Hoffmaster; William A Bower; Henry T Walke
Journal:  Am J Trop Med Hyg       Date:  2015-10-12       Impact factor: 2.345

8.  Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays.

Authors:  Susan L Welkos; Christopher P Klimko; Steven J Kern; Jeremy J Bearss; Joel A Bozue; Robert C Bernhards; Sylvia R Trevino; David M Waag; Kei Amemiya; Patricia L Worsham; Christopher K Cote
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

9.  Burkholderia pseudomallei misidentified by automated system.

Authors:  Christoph Weissert; Günter Dollenmaier; Philippe Rafeiner; Julia Riehm; Detlev Schultze
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

10.  The core and accessory genomes of Burkholderia pseudomallei: implications for human melioidosis.

Authors:  Siew Hoon Sim; Yiting Yu; Chi Ho Lin; R Krishna M Karuturi; Vanaporn Wuthiekanun; Apichai Tuanyok; Hui Hoon Chua; Catherine Ong; Sivalingam Suppiah Paramalingam; Gladys Tan; Lynn Tang; Gary Lau; Eng Eong Ooi; Donald Woods; Edward Feil; Sharon J Peacock; Patrick Tan
Journal:  PLoS Pathog       Date:  2008-10-17       Impact factor: 6.823

View more
  16 in total

Review 1.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

2.  A rare case: first description of a patient with melioidosis presenting with pericardial effusion in Germany.

Authors:  Elsharabassy M; Gummert J; Zange S; Tiefenbacher Cp
Journal:  Clin Res Cardiol       Date:  2021-04-23       Impact factor: 5.460

3.  Reply to "Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory-a Response from the Front Line".

Authors:  Peera Hemarajata; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2017-03       Impact factor: 5.948

4.  Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin.

Authors:  Delaney Burnard; Gemma Robertson; Andrew Henderson; Caitlin Falconer; Michelle J Bauer; Kyra Cottrell; Ian Gassiep; Robert Norton; David L Paterson; Patrick N A Harris
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

5.  Infected aneurysm after returning from Southeast Asia: think Burkholderia pseudomallei!

Authors:  Clément Auvens; Catherine Neuwirth; Lionel Piroth; Mathieu Blot
Journal:  BMJ Case Rep       Date:  2019-05-22

6.  The Brief Case: A Traveler's Tale-Burkholderia pseudomallei Infection in a Cystic Fibrosis Patient.

Authors:  I T Hettiarachchi; J Duckers; D Lau; R Dhillon
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

7.  Burkholderia pseudomallei: Challenges for the Clinical Microbiology Laboratory-a Response from the Front Line.

Authors:  David A B Dance; Direk Limmathurotsakul; Bart J Currie
Journal:  J Clin Microbiol       Date:  2017-03       Impact factor: 5.948

8.  Comparison of Mast Burkholderia Cepacia, Ashdown + Gentamicin, and Burkholderia Pseudomallei Selective Agar for the Selective Growth of Burkholderia Spp.

Authors:  Carola Edler; Henri Derschum; Mirko Köhler; Heinrich Neubauer; Hagen Frickmann; Ralf Matthias Hagen
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-01-09

9.  Aortic endograft infection secondary to Burkholderia pseudomallei: A case report and review of the literature.

Authors:  Sabrina Cheok; Le Si Cherie Gan; Shimin Jasmine Chung; Jack Kian Ch'ng
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-05-21

10.  Melioidosis in the Philippines.

Authors:  Peter Franz M San Martin; Joseph C Chua; Ralph Louie P Bautista; Jennifer M Nailes; Mario M Panaligan; David A B Dance
Journal:  Trop Med Infect Dis       Date:  2018-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.